← DocG Medical Summaries
Top Genetics Research Papers
1.
7.0
Efficacy and safety of risdiplam in patients with type 1 spinal muscular atrophy: a 3-year open-label extension of the two-part, phase 2 FIREFISH trial.
Overall: This uncontrolled but informative five-year extension reports substantial survival, respiratory, feeding, and motor benefits with no new safety signal, while its small selected cohort and lack of a comparator limit causal certainty and independent practice-changing impact.
2.
7.0
Menopausal Estrogen Therapy and Risk of Breast Cancer.
Overall: Randomized evidence supports a modest reduction in breast cancer with estrogen-only therapy after hysterectomy, but incomplete harm assessment and observational BRCA evidence limit definitive practice change.
3.
6.5
Hormone Therapy After Oophorectomy and Breast Cancer Risk in Women With BRCA Pathogenic Variant.
Overall: This clinically meaningful cohort offers useful reassurance about breast cancer risk with hormone therapy after oophorectomy in BRCA carriers, but residual confounding, imprecise estimates, and limited generalizability constrain its practice-changing impact.
4.
6.5
Genotype-Guided Antidepressant Prescribing for Patients With Depression: A Randomized Clinical Trial.
Overall: This relevant US randomized trial found no short-term improvement from genotype-guided SSRI prescribing but identified a potentially meaningful secondary remission benefit at six months that requires further confirmation.
5.
6.4
Breast and Ovarian Cancer Among Individuals Undergoing BRCA1 and BRCA2 Testing.
Overall: This large cohort provides clinically useful cancer-risk estimates across BRCA result categories, but it does not demonstrate that a specific change in screening or prevention improves patient outcomes.
6.
6.2
Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: a national observational cohort study of patients in the English NHS 2010-2022.
Overall: This large national cohort links regular surveillance with lower mortality, but unquantified effects, possible selection bias, lack of stage shift, and possible overdiagnosis limit causal interpretation and immediate practice-changing value.
7.
6.2
Automated reanalysis of genomic data for rare disease diagnostics at scale.
Overall: This large-scale evaluation shows promising diagnostic yield and workflow efficiency for automated genomic reanalysis, but lacks comparative validation and evidence that additional diagnoses improve patient outcomes.
8.
6.0
Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 Carriers.
Overall: This nationwide observational study reports a large reduction in breast cancer incidence with relatively few early major complications, but confounding, substantial procedural burden, and limited direct relevance to routine primary care constrain its impact.
9.
5.8
Survival estimates and their predictors in genetic frontotemporal dementia: an international, retrospective, cohort study.
Overall: Survival estimates are supported by a reasonably sized, externally validated international cohort and a hard clinical endpoint, but the retrospective design and unproven clinical utility of the risk index limit immediate practice change.
10.
5.8
Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants.
Overall: A striking reduction in heart-failure hospitalization among rare variant carriers is clinically promising, but the small exploratory genetic subgroup, wide uncertainty, specialized testing, and lack of reported harms make the result hypothesis-generating rather than practice-changing.
Score Guide:
9-10 Exceptional
7-8 Strong
5-6 Moderate
3-4 Weak
1-2 Poor
Top papers in other specialties
Emergency MedicineFamily Medicine / General Practice / Primary CareHospital MedicineInternal MedicineAllergy & ImmunologyCardiologyDermatologyEndocrinologyGastroenterologyGeriatricsHematologyInfectious DiseaseTropical & Travel MedicineCritical CareNephrologyNeurologyObesityOccupational & Environmental HealthOncologyPain MedicinePalliative & Supportive CarePhysical Medicine & RehabilitationPsychiatryPublic HealthPulmonology/RespirologyRheumatologyGynecologyObstetricsPediatrics (General)Pediatric Hospital MedicineNeonatologyPediatric Emergency MedicineAnesthesiologyOphthalmologyOtolaryngology (ENT)OrthopedicsUrologySurgery (Other)Sports MedicineAddiction Medicine